Kepler Capital analyst Christian Faitz maintained a Hold rating on Bayer (0P6S – Research Report) on January 21 and set a price target of €33.00. The company’s shares closed last Tuesday at ...

BERHAMPUR: Berhampur Municipal Corporation (BeMC) faces serious allegations of misappropriation after BJP leader Pitabas ...

In a report released today, Richard Vosser from J.P. Morgan maintained a Hold rating on Bayer (0P6S – Research Report), with a price target of €25.00. The company’s shares closed yesterday ...

Despite restructuring efforts, Bayer's financial outlook for 2025 remains weak, with anticipated declining earnings. Consensus estimates project $3-4 billion free cash flow for 2026-2027 ...

Although Bayer’s top-selling drug Xarelto lost market exclusivity in most geographies in 2024, the company still predicts it will see strong growth from the pharma business unit beginning in 2027.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Bayer’s BREEZE 2 has a useful on-board disc, containing 10 individual test strips. This means that it is not necessary to fumble around with loose strips and reload the meter every time to test.

Bayer argues PCB levels were safe, blames school for ignoring warnings Previous trials resulted in over $1.5 billion in verdicts Jan 14 (Reuters) - A Washington jury on Tuesday ordered Bayer ...

Bayer AG’s Monsanto unit stopped making toxic PCBs a half century ago, but the legal fallout lingers even as many of the building materials made with the chemicals are no longer used in US homes ...

In the United States, Bayer will continue its multipronged strategy to significantly contain the Roundup™ litigation. Having achieved favorable outcomes in 15 of the last 22 trials, the company ...

Bayer’s Parkinson’s disease cell therapy is moving into late-stage testing, with the upcoming trial set to be the first registrational phase 3 study for an investigational allogeneic cell ...